Prostate cancer mortality in Brazil 1990-2019: geographical distribution and trends.
Journal
Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
04
2021
accepted:
19
07
2021
entrez:
2
2
2022
pubmed:
3
2
2022
medline:
5
2
2022
Statut:
epublish
Résumé
To analyze the trend of prostate cancer mortality in the Brazilian population of 40 years of age and above. Time series ecological study of the mortality rates due to prostate cancer in men of 40 years of age and above, using data from the Global Burden of Disease 2019 (GBD). Age-standardized mortality rates were calculated, as well as the age-standardized rates by the GBD for the global population, per 100,000 inhabitants, for Brazil and its States, from 1990 to 2019. The annual average percent change (AAPC) was calculated to identify the mortality trends in Brazil, through linear regression using the Joinpoint Regression Program. The standardized rates of prostate cancer mortality in Brazil were 76.89 in 1990 and 74.96 deaths for every 100 thousand men ≥ 40 years of age in 2019, with a stability trend. By age group, it was observed a decreasing trend up to 79 years of age, and an increasing trend as of 80 years of age. The state of Bahia showed the highest increase in mortality in the period (1.2%/year), followed by Maranhão and Pernambuco (1.0 and 0.9%/year). A decrease of prostate cancer mortality was found in the Federal District, Goiás, Minas Gerais, Rio de Janeiro, Rio Grande do Sul, Roraima, Santa Catarina, São Paulo, and Sergipe. In Brazil, the standardized mortality rates show a trend toward stability from 1990 to 2019 and no pattern was observed for the trends according to the Brazilian States.
Identifiants
pubmed: 35107530
pii: S0037-86822022000500310
doi: 10.1590/0037-8682-0277-2021
pmc: PMC9020381
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0277Références
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):102-115
pubmed: 28658376
Lancet. 2014 Dec 6;384(9959):2027-35
pubmed: 25108889
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Am Fam Physician. 2016 May 1;93(9):764-70
pubmed: 27175954
Rev Bras Epidemiol. 2014 Apr-Jun;17(2):395-406
pubmed: 24918412
Rev Saude Publica. 2020 Dec 04;54:126
pubmed: 33295593
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Cien Saude Colet. 2017 Jan;22(1):279-290
pubmed: 28076551
JAMA. 2018 May 8;319(18):1901-1913
pubmed: 29801017
Actas Urol Esp. 2015 Dec;39(10):612-9
pubmed: 26166386
Am J Epidemiol. 2006 Aug 15;164(4):376-84
pubmed: 16829552
Rev Assoc Med Bras (1992). 2013 Jan-Feb;59(1):15-20
pubmed: 23440137
Cien Saude Colet. 2017 Jan;22(1):291-300
pubmed: 28076552
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Cancer Epidemiol. 2017 Oct;50(Pt A):53-59
pubmed: 28810175
Cad Saude Publica. 2014 Mar;30(3):559-66
pubmed: 24714945
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Cad Saude Publica. 2014 Nov;30(11):2451-2458
pubmed: 25493998
Cien Saude Colet. 2014 Apr;19(4):1263-74
pubmed: 24820609
N Engl J Med. 2009 Mar 26;360(13):1320-8
pubmed: 19297566
Lancet. 2018 Sep 1;392(10149):760-775
pubmed: 30037735
Public Health Rep. 2004 Mar-Apr;119(2):174-86
pubmed: 15192905
Cancer Treat Rev. 2018 Nov;70:30-40
pubmed: 30055462
Transl Androl Urol. 2021 Jan;10(1):7-11
pubmed: 33532289
Med Clin North Am. 2018 Mar;102(2):199-214
pubmed: 29406053
Cad Saude Publica. 2011 Feb;27(2):347-56
pubmed: 21359471
Public Health. 2019 Jul;172:70-80
pubmed: 31220754
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Int Braz J Urol. 2016 Nov-Dec;42(6):1081-1090
pubmed: 27622278
Cad Saude Publica. 2011 Jan;27(1):123-30
pubmed: 21340111
BMJ. 2018 Sep 5;362:k3581
pubmed: 30185545
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
CA Cancer J Clin. 2009 Jul-Aug;59(4):264-73
pubmed: 19564245
Rev Bras Epidemiol. 2017 May;20Suppl 01(Suppl 01):4-20
pubmed: 28658369
BMJ. 2018 Sep 05;362:k3519
pubmed: 30185521
Cancer Med. 2014 Dec;3(6):1644-55
pubmed: 25355624
Nat Rev Urol. 2014 Jun;11(6):317-23
pubmed: 24818853
Ann Oncol. 2017 Sep 01;28(9):2286-2297
pubmed: 28911064
Epidemiol Serv Saude. 2016 Oct-Dec;25(4):777-787
pubmed: 27869971
Popul Health Metr. 2017 Nov 22;15(1):39
pubmed: 29166948